By Kiku Steinfeld
Chicago, Oct. 2 – JPMorgan Chase Financial Co. LLC priced $165,000 of 0% digital dual directional contingent buffered notes due Sep. 10, 2020 linked to CVS Health Corp. shares, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
If the stock finishes at or above its initial level or falls by up to the 20% contingent buffer, the payout will be par plus 10.8%.
If the stock declines beyond 20% of its initial level, investors will be fully exposed to any losses.
J.P. Morgan Securities LLC is the agent.
Issuer: | JPMorgan Chase Financial Co. LLC
|
Guarantor: | JPMorgan Chase & Co.
|
Issue: | Digital dual directional contingent buffered notes
|
Underlying stock: | CVS Health Corp.
|
Amount: | $165,000
|
Maturity: | Sep. 10, 2020
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | If stock gains or falls by up to 20%, par plus 10.8%; otherwise, 1% loss for each 1% decline from initial level
|
Initial level: | $60.24
|
Contingent buffer: | 80% of initial level
|
Pricing date: | Aug. 23
|
Settlement date: | Aug. 28
|
Agent: | J.P. Morgan Securities LLC
|
Fees: | 1%
|
Cusip: | 48132FDD5
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.